University Hospitals Cleveland Medical Center partnered with Medtronic to begin using the medical device company’s new robotic neurosurgery platform.
UH performed the first case using the system Nov. 10. The Stealth Autoguide cranial robotic platform is designed for surgeries on adult and pediatric patients with neurological conditions. Using the platform, a surgeon can place an electrode or catheter in the brain or perform a biopsy with more precise movements while receiving continuous real-time visualization and feedback through the computer.
UH brain tumor and neuro-oncology center director Andrew Sloan, MD, said Medtronic chose the health system to begin using the tech because of its experience with laser interstitial thermal therapy, which is a technique used to treat primary and metastatic brain tumors that are hard to reach with conventional surgery.
More articles on health IT:
Former Cleveland Clinic CIO on retail competition: Hospitals must make digital changes or ‘become relic of the past’
States ranked by tech, science capabilities
COVID-19 vaccines must be accompanied by public education campaigns, experts say
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.